Leerink raised the firm’s price target on Align Technology to $349 from $327 and keeps a Market Perform rating on the shares. Align’s upside surprise showed the differentiation in products vs. other concerns across the dental market, with strong margin pull-through alongside better revenue growth, the firm says. Meanwhile, the increased full-year revenue guidance should show both ongoing aligner demand but also contributions from the Lumina scanner launch/ramp and further roll-out of the Invisalign Palatal Expander, notes Leerink.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- ALGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Align Technology price target raised to $400 from $350 at Stifel
- Align Technology launches integrated consumer campaign
- Align Technology price target raised to $350 from $340 at Stifel
- Early notable gainers among liquid option names on March 13th